Cadence Design Systems, trading under the symbol CDNS, has been bearing witness to a whirlwind of momentum. Its shares have flown high with a jaw-dropping 67% rally year to date, outpacing the sub-industry’s 51.7% and the S&P Composite’s 18.5% growth. With robust fundamentals and prospective growth avenues, this stock could be an electrifying investment opportunity. The company currently holds a Zacks Rank #2 (Buy) and flaunts a Growth Score of B, making it an appealing prospect according to Zacks’ unique methodology.
Firing on All Cylinders: What’s Fueling the Growth?
Cadence’s success story is underpinned by the strong demand for its diverse product portfolio, which spans across all segments. The third quarter of 2023 saw CDNS deliver impressive results with non-GAAP earnings of $1.26 per share, trumping the Zacks Consensus Estimate by 4.1% and leaping a substantial 18.9% year over year. Revenues also surged, reaching $1.023 billion, surpassing the Zacks Consensus Estimate by 1.7% and marking a 13.3% uptick year over year.
With a glowing performance, the company raised its full-year guidance, citing transformative generational trends like AI, hyperscale computing, 5G, and autonomous driving as catalysts for a solid design activity. Additionally, the rise in the production of 3D-IC and chiplet designs, along with growing interest from system companies in custom silicon, laid a sturdy foundation for future growth.
Bolstering Growth through Strategic Moves
Amidst all this, strategic acquisitions played a pivotal role in propelling CDNS’ top-line growth. The acquisition of Intrinsix Corporation from CEVA, a leading provider of design engineering solutions for the U.S. aerospace and defense industry, and the earlier acquisition of Rambus SerDes and memory interface PHY IP business from Rambus, signify the company’s aggressive stance in extending its reach across geographies and key vertical markets. Furthermore, the company’s strong cash position and healthy cash flow have enabled it to continue with its shareholder-friendly initiatives, including hefty share repurchases.
Despite the impressive strides, rising costs related to research and development could put the brakes on margins in the near term. Moreover, fierce competition and unpredictable macroeconomic conditions are perennial concerns for the company. Nonetheless, the stock’s earnings are anticipated to ascend 19.7% and 13.4% on a year-over-year basis in 2023 and 2024, respectively. Revenues for the same periods are expected to surge by 14.8% and 10.9%, painting a promising outlook for the future.
Other Thriving Stocks
Several other stocks making waves in the technology space, such as Adobe, Synopsys, and Watts Water Technologies, have also been grabbing attention with their impressive growth trajectories and warrant consideration.
From the humming engine of the stock market, the name that has been causing a stir is yet to be seen. It’s poised to make a splash as it emerges from a chasm and possesses a bustling pipeline of projects with the potential to flip the table for patients grappling with liver, lung, and blood-related diseases. Keep an eye on this timely investment that could potentially outshine recent stocks that have surged massively.
If you like what you’re hearing, you can read this article on Zacks.com here.
For more insights and recommendations from Zacks Investment Research, you can also visit their site.